Akanocure is a drug development company with a focus on orphan and unmet needs in oncology.
Akanocure Pharmaceuticals has raised $5K in total funding. The most recent round was Grant. The last funding was announced in August 2022.
Akanocure Pharmaceuticals's investors include National Science Foundation, Elevate Ventures, First Flight Venture Center, Purdue Foundry, Purdue Ag-celerator.
Akanocure Pharmaceuticals is headquartered in West Lafayette, United States.
Akanocure is a drug development company with a focus on orphan and unmet needs in oncology.
Akanocure Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akanocure Pharmaceuticals — Funding & Investors." VCBacked, August 10, 2022, https://www.vcbacked.co/company/akanocure-pharmaceuticals. Accessed October 30, 2026.
VCBacked. (2022). Akanocure Pharmaceuticals — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/akanocure-pharmaceuticals
{{cite web |title=Akanocure Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/akanocure-pharmaceuticals |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated